At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
Nagendrakumar B Singanallur, Petrus Jansen van Vuren, Alexander J McAuley, Matthew P Bruce, Michael J Kuiper, Stella M Gwini, Shane Riddell, Sarah Goldie, Trevor W Drew, Kim R Blasdell, Mary Tachedjian, Shruthi Mangalaganesh, Simran Chahal, Leon Caly, Julian D Druce, View ORCID ProfileJennifer A Juno, View ORCID ProfileStephen J Kent, Adam K Wheatley, View ORCID ProfileSeshadri S Vasan
doi: https://doi.org/10.1101/2022.02.20.22271237
Nagendrakumar B Singanallur
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Petrus Jansen van Vuren
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Alexander J McAuley
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Matthew P Bruce
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Michael J Kuiper
2Data61, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Docklands, VIC 3008, Australia
Stella M Gwini
3University Hospital Geelong, Barwon Health, Geelong, VIC 3220, Australia
Shane Riddell
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Sarah Goldie
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Trevor W Drew
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Kim R Blasdell
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Mary Tachedjian
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Shruthi Mangalaganesh
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
4Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3168, Australia
Simran Chahal
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
Leon Caly
5Victorian Infectious Diseases Reference Laboratory (VIDRL), The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
Julian D Druce
5Victorian Infectious Diseases Reference Laboratory (VIDRL), The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
Jennifer A Juno
6Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
Stephen J Kent
6Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
Adam K Wheatley
6Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
Seshadri S Vasan
1Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Centre for Disease Preparedness (ACDP), Geelong, VIC 3220, Australia
7Department of Health Sciences, University of York, York, YO10 5DD, United Kingdom
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.
Posted April 15, 2022.
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
Nagendrakumar B Singanallur, Petrus Jansen van Vuren, Alexander J McAuley, Matthew P Bruce, Michael J Kuiper, Stella M Gwini, Shane Riddell, Sarah Goldie, Trevor W Drew, Kim R Blasdell, Mary Tachedjian, Shruthi Mangalaganesh, Simran Chahal, Leon Caly, Julian D Druce, Jennifer A Juno, Stephen J Kent, Adam K Wheatley, Seshadri S Vasan
medRxiv 2022.02.20.22271237; doi: https://doi.org/10.1101/2022.02.20.22271237
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
Nagendrakumar B Singanallur, Petrus Jansen van Vuren, Alexander J McAuley, Matthew P Bruce, Michael J Kuiper, Stella M Gwini, Shane Riddell, Sarah Goldie, Trevor W Drew, Kim R Blasdell, Mary Tachedjian, Shruthi Mangalaganesh, Simran Chahal, Leon Caly, Julian D Druce, Jennifer A Juno, Stephen J Kent, Adam K Wheatley, Seshadri S Vasan
medRxiv 2022.02.20.22271237; doi: https://doi.org/10.1101/2022.02.20.22271237
Subject Area
Subject Areas
- Addiction Medicine (343)
- Allergy and Immunology (666)
- Anesthesia (180)
- Cardiovascular Medicine (2630)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12183)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4071)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2628)
- Health Policy (998)
- Hematology (362)
- HIV/AIDS (845)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (431)
- Neurology (3840)
- Nursing (209)
- Nutrition (571)
- Oncology (2011)
- Ophthalmology (582)
- Orthopedics (239)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (74)
- Pathology (471)
- Pediatrics (1109)
- Primary Care Research (449)
- Public and Global Health (6504)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (401)
- Sports Medicine (341)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)